CIRM-funded clinical trial aimed at blocking HIV/AIDS in people gets the go ahead
An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the FDA to begin a clinical trial in people. CIRM, California’s stem cell agency, is funding that trial. March 03, 2015